{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:04:37Z","timestamp":1777971877195,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":868,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Boston Scientific"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jcin.2010.10.016","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T02:40:36Z","timestamp":1306118436000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Role of Pioglitazone in the Prevention of Restenosis and Need for Revascularization After Bare-Metal Stent Implantation"],"prefix":"10.1016","volume":"4","author":[{"given":"Dhavalkumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Walitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Wilensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2010.10.016_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2010.10.016_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials","volume":"119","author":"Bavry","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jcin.2010.10.016_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2010.10.016_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.CIR.95.6.1366","article-title":"Increase restenosis in diabetes mellitus after coronary interventions is due to exaggerated neointimal hyperplasia: a serial intravascular ultrasound study","volume":"95","author":"Kornowski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.016_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.016_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","article-title":"Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes","volume":"92","author":"Hong","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2010.10.016_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinedione","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2010.10.016_bib8","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on death and major adverse cardiovascular events in patient with type 2 diabetes mellitus","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2010.10.016_bib9","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/bioinformatics\/bth371","article-title":"Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes","volume":"20","author":"Hsiao","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcin.2010.10.016_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.28.7.1547","article-title":"A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia","volume":"28","author":"Goldberg","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcin.2010.10.016_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2010.10.016_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjopharm.2006.06.003","article-title":"The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials","volume":"4","author":"Rajagopalan","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jcin.2010.10.016_bib13","doi-asserted-by":"crossref","first-page":"e6112","DOI":"10.1371\/journal.pone.0006112","article-title":"Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis","volume":"4","author":"Clar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jcin.2010.10.016_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","article-title":"Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells","volume":"94","author":"Marx","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2010.10.016_bib15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2005.03.041","article-title":"Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study","volume":"45","author":"Pf\u00fctzner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2010.10.016_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jcin.2009.04.007","article-title":"A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study)","volume":"2","author":"Takagi","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2010.10.016_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/hrt.2008.162842","article-title":"Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation","volume":"95","author":"Kaneda","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2010.10.016_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2007.02.022","article-title":"Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome","volume":"153","author":"Katayama","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.10.016_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diacare.29.01.06.dc05-1170","article-title":"A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes","volume":"29","author":"Nishio","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcin.2010.10.016_bib20","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/CIRCULATIONAHA.105.535484","article-title":"Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients","volume":"112","author":"Marx","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.016_bib21","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1016\/S0002-8703(03)00146-7","article-title":"Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study","volume":"146","author":"Takagi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.10.016_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fjc.0000249891.40714.2a","article-title":"Peroxisome proliferator-activated receptor y ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit","volume":"48","author":"Pakala","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jcin.2010.10.016_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/01.ATV.0000251021.28725.e8","article-title":"Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-B and MCP-1","volume":"27","author":"Joner","year":"2007","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jcin.2010.10.016_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.atherosclerosis.2007.08.030","article-title":"Pioglitazone attenuates neointimal thickening via suppression of early inflammatory response in a porcine coronary after stenting","volume":"197","author":"Kasai","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcin.2010.10.016_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ahj.2007.04.005","article-title":"Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials","volume":"154","author":"Rosmarakis","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2010.10.016_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.05.029","article-title":"Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials","volume":"202","author":"Geng","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcin.2010.10.016_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jcin.2010.10.016_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2840-6-33","article-title":"Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions","volume":"6","author":"Little","year":"2007","journal-title":"Cadiovasc Diabetol"},{"key":"10.1016\/j.jcin.2010.10.016_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.vph.2006.10.001","article-title":"Long term effect of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats","volume":"46","author":"Desouza","year":"2006","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jcin.2010.10.016_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/hc3001.092040","article-title":"Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduced intimal hyperplasia","volume":"104","author":"Aizawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.016_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.98.3.224","article-title":"Neointimal tissue response at sites of coronary stenting in humans; microscopic, histological and immunohistochemical analyses","volume":"98","author":"Komastu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2010.10.016_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cardiores.2004.11.027","article-title":"The effect of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation","volume":"65","author":"Li","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcin.2010.10.016_bib33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial","volume":"31","author":"Komajda","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2010.10.016_bib34","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study: a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2010.10.016_bib35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimeperide on progression of coronary atherosclerosis in the patient with type 2 diabetes: the PERISCOPE randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2010.10.016_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:57:01Z","timestamp":1761847021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879811000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1936879811000173"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2010.10.016","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Pioglitazone in the Prevention of Restenosis and Need for Revascularization After Bare-Metal Stent Implantation","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2010.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}